ARS Pharmaceuticals

FDA denies approval for Neffy, ARS Pharmaceuticalsâ needle-free EpiPen alternative, citing safety concerns
Anika Sharma
While positive votes from FDA advisory committees often bode well for drug approvals, ARS Pharmaceuticals experienced an unexpected setback when ...